By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Hegenheimermattweg 125

Allschwil    CH-4123  Switzerland
Phone: 41-61-567-1600 Fax: 41-61-567-1601



Drug Discovery

Company News
Polyphor Appoints Michael Altorfer As New CEO And Strengthens Executive Management Team 3/17/2015 10:12:40 AM
Polyphor Develops The Elastase Inhibitor POL6014 For Rare Lung Diseases Using PARI Pharma’s Eflow Technology Inhalation Device 1/9/2015 7:53:56 AM
Polyphor’s Lead Antibiotic POL7080 Receives Qualified Infectious Disease Product (QIDP) Designation From The FDA 11/12/2014 9:14:16 AM
Roche (RHHBY) to Pay Polyphor Up to $548 Million for Superbug Antibiotic 11/4/2013 7:13:44 AM
Polyphor Achieves First Milestone in Macrocycle Drug Discovery Collaboration With Boehringer Ingelheim Corporation 7/31/2013 9:15:00 AM
Polyphor Attracts Senior Pharma Professionals to Strengthen Its Board of Directors 6/11/2013 8:51:41 AM
Polyphor Reports Successful Phase I Results for Its Pseudomonas Selective Antibiotic POL7080 3/4/2013 11:46:40 AM
Polyphor Signs MacroFinder® Collaboration With Boehringer Ingelheim Corporation 6/12/2012 7:47:36 AM
Axxam srl and Polyphor Participate in a Research Partnership for the Treatment of Type-2 Diabetes Funded by the EU 7/27/2011 9:32:12 AM
Polyphor Announces First PEMfinder(R) collaboration with Big Pharma, Novartis Pharmaceuticals Corporation (NVS) 5/6/2010 10:52:14 AM